Rep. Andy Harris (R-MD) (Tasos Katopodis/Pool via AP Images)
September 23, 2020 11:07 AM EDTUpdated September 26, 07:27 AM
FDA+
Coronavirus

Up­dat­ed: The mi­cro-cap that tapped a mask-skep­tic con­gress­man for their Covid DSMB is ap­ply­ing for an EUA. Their ev­i­dence? 21 pa­tients

Jason Mast

Editor

Pub­lish­ers note: Af­ter this re­port was pub­lished, Neu­roRx CEO Jonathan Javitt emailed End­points with more in­for­ma­tion on the DSMB, which we added to the sto­ry …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ma­jor PBM re­forms fea­ture in Con­gress' year-end spend­ing bill

UCB, No­var­tis say a Phase 2a Parkin­son's study failed

Pfiz­er’s mes­sage to in­vestors: The ship is steady­ing in 2025 (even if Wash­ing­ton is tur­bu­lent)

Chica­go’s biotech scene is grow­ing up. What’s fu­el­ing it?

In sur­prise move, FDA's No. 2 Bum­pus to leave agency at end of 2024

Jazz Phar­ma­ceu­ti­cals CEO and co-founder Bruce Cozadd is re­tir­ing

A service from the Financial Times